Clare Cutland to Streptococcal Vaccines
This is a "connection" page, showing publications Clare Cutland has written about Streptococcal Vaccines.
Connection Strength
0,610
-
Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development. PLoS One. 2016; 11(12):e0169101.
Score: 0,133
-
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. Lancet Infect Dis. 2016 08; 16(8):923-34.
Score: 0,127
-
Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1). Emerg Infect Dis. 2015 Apr; 21(4):638-45.
Score: 0,118
-
Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa. Vaccine. 2014 Apr 07; 32(17):1954-63.
Score: 0,109
-
Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates? Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S89-S99.
Score: 0,035
-
Invasive Group B Streptococcal Disease in South Africa: Importance of Surveillance Methodology. PLoS One. 2016; 11(4):e0152524.
Score: 0,032
-
Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial. Lancet Infect Dis. 2016 May; 16(5):546-555.
Score: 0,031
-
Distribution of pilus islands of group B streptococcus associated with maternal colonization and invasive disease in South Africa. J Med Microbiol. 2013 Feb; 62(Pt 2):249-253.
Score: 0,025